NeOnc, a biotech company helmed by Dr. Thomas Chen, brings the first non-invasive intranasal drug delivery for brain cancer into the spotlight. With this revolutionary treatment, NeOnc is poised to ...

Bypassing the blood-brain barrier (BBB) has been one of the greatest hurdles in the development of treatments for patients living with brain cancer with glioblastomas for a long time now. When a ...

Researchers have generated more preclinical evidence that intranasal delivery can get antibodies to the brain, presenting data that suggest the administration route can achieve concentrations close to ...

Please provide your email address to receive an email when new articles are posted on . NeOnc’s nebulizer bypasses the blood-brain barrier to deliver drugs directly to olfactory nerve endings.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Thanks to the incredible medical innovation seen in the ...

When it comes to treating cancer, the world has come a long way. However, there’s one particular cancer that even world-renowned physicians struggle to treat: brain cancer. That’s because the ...

Many people think of a cure for cancer as a single medical breakthrough, but in all likelihood, it will be a combination of medical and biotech innovations. NeOnc, Inc — a biotech company headed by ...

Research by Wake Forest University School of Medicine provides a crucial method for future Alzheimer’s disease treatment trials and reveals key differences in how the drug is absorbed in people with ...

BERWYN, Pa.--(BUSINESS WIRE)--Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic ...

A new imaging study from Wake Forest University School of Medicine has shown that insulin administered intranasally can reach specific brain regions associated with memory and cognition in older ...